Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040305429> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W2040305429 endingPage "311" @default.
- W2040305429 startingPage "311" @default.
- W2040305429 abstract "The relative effects of radiation dose escalation (RDE) and androgen suppression (AS) duration on local prostatic progression (LP) remain unclear.We addressed this in the TROG 03.04 RADAR trial by incorporating a RDE programme by stratification at randomisation. Men were allocated 6 or 18 months AS ± 18 months zoledronate (Z). The main endpoint was a composite of clinically diagnosed LP or PSA progression with a PSA doubling time ⩾6 months. Fine and Gray competing risk modelling with adjustment for site clustering produced cumulative incidence estimates at 6.5 years for each RDE group.Composite LP declined coherently in the 66, 70 and 74 Gy external beam dosing groups and was lowest in the high dose rate brachytherapy boost (HDRB) group. At 6.5 years, adjusted cumulative incidences were 22%, 15%, 13% and 7% respectively. Compared to 6 months AS, 18 months AS also significantly reduced LP (p < 0.001). Post-radiation urethral strictures were documented in 45 subjects and increased incrementally in the dosing groups. Crude incidences were 0.8%, 0.9%, 3.8% and 12.7% respectively.RDE and increasing AS independently reduce LP and increase urethral strictures. The risks and benefits to the individual must be balanced when selecting radiation dose and AS duration." @default.
- W2040305429 created "2016-06-24" @default.
- W2040305429 creator A5008661841 @default.
- W2040305429 creator A5022294800 @default.
- W2040305429 creator A5022821954 @default.
- W2040305429 creator A5024582900 @default.
- W2040305429 creator A5054669965 @default.
- W2040305429 creator A5055102504 @default.
- W2040305429 creator A5055882141 @default.
- W2040305429 creator A5064556770 @default.
- W2040305429 creator A5075307062 @default.
- W2040305429 date "2009-09-01" @default.
- W2040305429 modified "2023-09-26" @default.
- W2040305429 title "5170 Breast cancer – Clinical early disease Neoadjuvant versus adjuvant chemotherapy for women with operable breast cancer: a matched-pair analysis and prognostic factors on overall survival" @default.
- W2040305429 doi "https://doi.org/10.1016/s1359-6349(09)71062-6" @default.
- W2040305429 hasPublicationYear "2009" @default.
- W2040305429 type Work @default.
- W2040305429 sameAs 2040305429 @default.
- W2040305429 citedByCount "0" @default.
- W2040305429 crossrefType "journal-article" @default.
- W2040305429 hasAuthorship W2040305429A5008661841 @default.
- W2040305429 hasAuthorship W2040305429A5022294800 @default.
- W2040305429 hasAuthorship W2040305429A5022821954 @default.
- W2040305429 hasAuthorship W2040305429A5024582900 @default.
- W2040305429 hasAuthorship W2040305429A5054669965 @default.
- W2040305429 hasAuthorship W2040305429A5055102504 @default.
- W2040305429 hasAuthorship W2040305429A5055882141 @default.
- W2040305429 hasAuthorship W2040305429A5064556770 @default.
- W2040305429 hasAuthorship W2040305429A5075307062 @default.
- W2040305429 hasConcept C120665830 @default.
- W2040305429 hasConcept C121332964 @default.
- W2040305429 hasConcept C121608353 @default.
- W2040305429 hasConcept C126322002 @default.
- W2040305429 hasConcept C126894567 @default.
- W2040305429 hasConcept C143998085 @default.
- W2040305429 hasConcept C151032500 @default.
- W2040305429 hasConcept C2777416452 @default.
- W2040305429 hasConcept C2777863537 @default.
- W2040305429 hasConcept C2989005 @default.
- W2040305429 hasConcept C509974204 @default.
- W2040305429 hasConcept C530470458 @default.
- W2040305429 hasConcept C61511704 @default.
- W2040305429 hasConcept C71924100 @default.
- W2040305429 hasConcept C72563966 @default.
- W2040305429 hasConcept C88879693 @default.
- W2040305429 hasConceptScore W2040305429C120665830 @default.
- W2040305429 hasConceptScore W2040305429C121332964 @default.
- W2040305429 hasConceptScore W2040305429C121608353 @default.
- W2040305429 hasConceptScore W2040305429C126322002 @default.
- W2040305429 hasConceptScore W2040305429C126894567 @default.
- W2040305429 hasConceptScore W2040305429C143998085 @default.
- W2040305429 hasConceptScore W2040305429C151032500 @default.
- W2040305429 hasConceptScore W2040305429C2777416452 @default.
- W2040305429 hasConceptScore W2040305429C2777863537 @default.
- W2040305429 hasConceptScore W2040305429C2989005 @default.
- W2040305429 hasConceptScore W2040305429C509974204 @default.
- W2040305429 hasConceptScore W2040305429C530470458 @default.
- W2040305429 hasConceptScore W2040305429C61511704 @default.
- W2040305429 hasConceptScore W2040305429C71924100 @default.
- W2040305429 hasConceptScore W2040305429C72563966 @default.
- W2040305429 hasConceptScore W2040305429C88879693 @default.
- W2040305429 hasIssue "2" @default.
- W2040305429 hasLocation W20403054291 @default.
- W2040305429 hasOpenAccess W2040305429 @default.
- W2040305429 hasPrimaryLocation W20403054291 @default.
- W2040305429 hasRelatedWork W2061780476 @default.
- W2040305429 hasRelatedWork W2163676795 @default.
- W2040305429 hasRelatedWork W2413875651 @default.
- W2040305429 hasRelatedWork W2759031936 @default.
- W2040305429 hasRelatedWork W2793434371 @default.
- W2040305429 hasRelatedWork W2810905056 @default.
- W2040305429 hasRelatedWork W2972384824 @default.
- W2040305429 hasRelatedWork W377899687 @default.
- W2040305429 hasRelatedWork W4285804722 @default.
- W2040305429 hasRelatedWork W4322772323 @default.
- W2040305429 hasVolume "7" @default.
- W2040305429 isParatext "false" @default.
- W2040305429 isRetracted "false" @default.
- W2040305429 magId "2040305429" @default.
- W2040305429 workType "article" @default.